Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol for Quality of Life in Esophageal Cancer
NCT02644408Phase 3Completed
- Sponsor
- First Affiliated Hospital of Henan University of Science and Technology
- Start
- Oct 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by First Affiliated Hospital of Henan University of Science and Technology. Started Oct 2014; status: completed.
02
Drugs
megestrol
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02644408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644408.